Frederic Pouliot, Ph.D.
Affiliations: | 2004 | Universite Laval (Canada) |
Area:
Cell Biology, Oncology, Molecular BiologyGoogle:
"Frederic Pouliot"Parents
Sign in to add mentor| Claude Labrie | grad student | 2004 | Universite Laval (Canada) | |
| (Les "bone morphogenetic proteins" et le cancer du sein.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Tajzler C, Tanguay S, Mallick R, et al. (2020) Determining generalizability of the Canadian Kidney Cancer information system (CKCis) to the entire Canadian kidney cancer population. Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada. 14: E499-E506 |
| Hotte SJ, Finelli A, Chi KN, et al. (2020) Real-world management of advanced prostate cancer: A description of management practices of community-based physicians and prostate cancer specialists. Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada |
| Asselin C, Finelli A, Breau RH, et al. (2020) Does renal tumor biopsies for small renal carcinoma increase the risk of upstaging on final surgery pathology report and the risk of recurrence? Urologic Oncology |
| Ghavimi S, Saarela O, Pouliot F, et al. (2020) Achieving the "trifecta" with open versus minimally invasive partial nephrectomy. World Journal of Urology |
| Shiff B, Breau RH, Patel P, et al. (2020) Impact of Time-To-Surgery and Surgical Delay on Oncologic Outcomes for Renal Cell Carcinoma. The Journal of Urology. 101097JU000000000000 |
| Kokorovic A, So AI, Hotte SJ, et al. (2020) A Canadian framework for managing prostate cancer during the COVID-19 pandemic: Recommendations from the Canadian Urologic Oncology Group and the Canadian Urological Association. Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada |
| Saad F, Fleshner N, Pickles T, et al. (2020) Testosterone Breakthrough Rates during Androgen Deprivation Therapy for Castration Sensitive Prostate Cancer. The Journal of Urology. 101097JU000000000000 |
| So AI, Chi KN, Danielson B, et al. (2020) Canadian Urological Association-Canadian Urologic Oncology Group guideline on metastatic castration-naive and castration-sensitive prostate cancer. Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada. 14: 17-23 |
| Meziou S, Ringuette Goulet C, Hovington H, et al. (2020) GLUT1 expression in high-risk prostate cancer: correlation with F-FDG-PET/CT and clinical outcome. Prostate Cancer and Prostatic Diseases |
| Yu EY, Laidley D, Pouliot F, et al. (2020) A multicenter, randomized, controlled phase II study: Efficacy and safety of PSMA-targeted radioligand therapy I-131-1095 (1095) plus enzalutamide (enza) in 18F-DCFPyL PSMA scan avid, metastatic castration-resistant prostate cancer (mCRPC) patients post-abiraterone (abi) progression (ARROW). Journal of Clinical Oncology. 38 |